Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain
T. J. C. Tan, M. Yuan, K. Kuzelka, G. C. Padron, J. R. Beal, X. Chen, Y. Wang, J. Rivera-Cardona, X. Zhu, B. M. Stadtmueller, C. B. Brooke, I. A. Wilson, N. C. Wu
Abstract
Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short CDR H3. Germline-encoded sequence motifs in CDRs H1 and H2 play a major role, but whether any common motifs are present in CDR H3, which is often critical for binding specificity, have not been elucidated. Here, we identify two public clonotypes of IGHV3-53/3-66 RBD antibodies with a 9-residue CDR H3 that pair with different light chains. Distinct sequence motifs on CDR H3 are present in the two public clonotypes that appear to be related to differential light chain pairing. Additionally, we show that Y58F is a common somatic hypermutation that results in increased binding affinity of IGHV3-53/3-66 RBD antibodies with a short CDR H3. Overall, our results advance fundamental understanding of the antibody response to SARS-CoV-2.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain
N. C. Wu, M. Yuan, … I. A. Wilson·bioRxiv·Jul 26, 2020
- Structural basis of a public antibody response to SARS-CoV-2
M. Yuan, H. Liu, … I. A. Wilson·SciencePeer-reviewed·Aug 28, 2020
- Paired heavy and light chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses
B. B. Banach, G. Cerutti, … B. J. DeKosky·bioRxiv·Dec 31, 2020
- Stereotypic Neutralizing VH Clonotypes Against SARS-CoV-2 RBD in COVID-19 Patients and the Healthy Population
- Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies
C. O. Barnes, A. P. West, … P. J. Bjorkman·bioRxiv·May 28, 2020
- A large-scale systematic survey of SARS-CoV-2 antibodies reveals recurring molecular features